FEC regimen
WikiDoc Resources for FEC regimen |
Articles |
---|
Most recent articles on FEC regimen Most cited articles on FEC regimen |
Media |
Powerpoint slides on FEC regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on FEC regimen at Clinical Trials.gov Clinical Trials on FEC regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on FEC regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on FEC regimen Discussion groups on FEC regimen Patient Handouts on FEC regimen Directions to Hospitals Treating FEC regimen Risk calculators and risk factors for FEC regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for FEC regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:CEF; CEF Regimen; CTX/EPI/5-FU; Cyclophosphamide/Epirubicin/Fluorouracil; FEC; FEC 100; FEC Regimen; FEC regimen; Fluorouracil-Epirubicin-Cytoxan Regimen
Overview
FEC regimen refers to a regimen consisting of fluorouracil, epirubicin and cyclophosphamide used in the adjuvant setting and also for the treatment of recurrent and metastatic breast cancer.[1]
Regimen
FFluorouracil
EEpirubicin
CCyclophosphamide